NASDAQ · STOCK
Pfizer Inc.
$24.19
52W $23.11 – $28.75
68/100
$138.21B
18.4
0.29
Price History (6M)
Executive Summary
5 analysts weighed in with 60% agreement on a bullish lean. Growth Analyst: 4 consecutive earnings beats -- consistent execution. Overall recommendation: BUY.
Bull & Bear Case
Bull Case
- Positive MACD histogram signals bullish momentum.
- Daily volatility (ATR%) above ~3% is treated as elevated risk.
Bear Case
- Daily trend is down — entering long positions against the trend.
- Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
- Lower Highs / Lower Lows structure confirms bearish price action.
AI Investment Committee
Committee Consensus
As of July 11, 2026
Overall Committee Score
68/100
Agreement
60%
Analysts
5
Conviction
Moderate
Growth Analyst
bullish
82
/ 100 · Moderate confidence
Strong, accelerating growth with consistent execution
+ 4 consecutive earnings beats -- consistent execution
Technical Analyst
neutral
56
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
− Price structure making lower highs and lower lows
Macro Analyst
bullish
70
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
neutral
53
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager
bullish
75
/ 100 · Low confidence
The existing book is healthy enough that position-sizing here is a matter of stock selection, not portfolio constraints
+ Portfolio position concentration is currently healthy
Technical Analysis
RSI (14)
44.8
Neutral
MACD Histogram
0.011
Bullish Momentum
Trend Direction
Downtrend
Weekly: Downtrend
Market Structure
Lh Ll
Support
$23.92
Resistance
$26.05
Bollinger %B
0.35
Inside Bands
Price vs Moving Averages
EMA 9
$24.20
Below
EMA 21
$24.61
Below
EMA 50
$25.30
Below
EMA 200
$25.80
Below
Fundamental Analysis
Valuation
92
Growth
57
Profitability
59
Financial Health
59
Valuation
P/E Ratio
18.4×
P/B Ratio
1.64×
PEG Ratio
—
Dividend Yield
7.09%
52W High
$28.75
52W Low
$23.11
Quality & Growth
ROE
837.0%
ROA
361.0%
Gross Margin
7480.0%
Operating Margin
1536.0%
Revenue Growth YoY
+136.0%
Debt / Equity
0.75
AI Fundamental Assessment
P/E ratio of 18.4 (inexpensive relative to a 15-40x range); Price-to-book of 1.6x; Revenue growth (YoY) of 1.4%; EPS growth (YoY) of -5.3%; Return on equity of 8.4%; Return on assets of 3.6%; Net margin of 11.8%; Gross margin of 74.8%; Current ratio of 1.16 (tight short-term liquidity); Debt-to-equity of 0.75; Most recent quarter beat estimates by 3.5%; 4 consecutive earnings beats; EPS growth accelerating (-24.1% -> +13.6% QoQ); Analyst estimates rising over recent quarters
Key Risks
- Daily trend is down — entering long positions against the trend.
- Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
- Lower Highs / Lower Lows structure confirms bearish price action.
This risk summary is generated from quantitative data signals, not qualitative opinion. All investors should conduct their own due diligence. This is not financial advice.
Get the Full PFE Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Mobile